Health Care: Drugs

Dr Reddy Laboratories Ltd (RDY: NYSE)

$48.95 n/a | n/a%
09/15/14 - 04:02 PM ET
Company Income Statement
Mar 2014 Mar 2013 Mar 2012 Mar 2011
Sales 2.21B 2.14B 1.90B 1.67B
Cost of Sales 823.18M 921.54M 751.34M 678.32M
Gross Operating Profit 1.39B 1.22B 1.15B 994.81M
Selling, General, and Administrative Expenses 648.06M 617.27M 567.49M 530.63M
Research & Development 207.24M 141.05M 116.20M 113.34M
Operating Income before D & A (EBITDA) 530.07M 457.11M 466.70M 350.83M
Depreciation & Amortization 118.74M 101.99M 102.48M 92.92M
Interest Income 27.97M 27.17M 24.12M 3.88M
Other Income - Net 0.00 0.00 15.04M 24.98M
Special Income / Charges 23.66M 32.92M -20.45M 0.00
Total Income Before Interest Expenses (EBIT) 465.87M 417.12M 383.99M 286.83M
Interest Expense 21.29M 18.71M 20.98M 8.11M
Pre-Tax Income 444.59M 398.40M 363.02M 278.72M
Income Taxes 85.12M 90.06M 82.65M 31.43M
Minority Interest 0.00 -18.38K 0.00 0.00
Net Income From Continuing Operations 359.47M 308.34M 280.37M 247.30M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 359.47M 308.34M 280.37M 247.30M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 359.47M 308.36M 280.37M 247.30M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
335.80M 275.42M 300.82M 247.30M
Preferred Dividends
Net Income Available To Common 359.47M 308.34M 280.37M 247.30M
Basic EPS from Continuing Ops. 2.11 1.82 1.65 1.46
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 2.11 1.82 1.65 1.46
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 2.11 1.82 1.65 1.46
Basic Normalized Net Income/Share 1.97 1.62 1.78 1.46
EPS fr Continuing Ops. 2.11 1.81 1.65 1.45
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 2.11 1.81 1.65 1.45
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 2.11 1.81 1.65 1.45
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.97 1.62 1.77 1.45
Dividends Paid per Share 0.26 0.23 0.23 0.22

Portfolios with RDY

Latest RDY Headlines from TheStreet

More Financial News for RDY

Press Releases for RDY

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter